Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Osteonecrosis in protease inhibitor-treated patients.

Bonfanti P, Grabbuti A, Carradori S, Pusterla L, Parrazini F, Landonio S, Quirino T; Italian Coordination for the Study of Allergies and HIV Infection.

Orthopedics. 2001 Mar;24(3):271-2.

PMID:
11300292
2.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677
3.

Protease inhibitor plasma concentrations in HIV antiretroviral therapy.

Justesen US.

Dan Med Bull. 2008 Nov;55(4):165-85. Review.

PMID:
19232158
4.

Bone disorders in human immunodeficiency virus infection.

Glesby MJ.

Clin Infect Dis. 2003;37 Suppl 2:S91-5. Review.

PMID:
12942380
5.

Avascular necrosis of the femoral head in HIV infected patients.

Matos MA, Alencar RW, Matos SS.

Braz J Infect Dis. 2007 Feb;11(1):31-4. Review.

6.

Sex differences in adverse reactions to antiretroviral drugs.

Ofotokun I, Pomeroy C.

Top HIV Med. 2003 Mar-Apr;11(2):55-9. Review.

7.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
8.

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment.

Barragan P, Podzamczer D.

Expert Opin Pharmacother. 2008 Sep;9(13):2363-75. doi: 10.1517/14656566.9.13.2363 . Review.

PMID:
18710360
9.

Adverse drug reactions to protease inhibitors.

Manchanda T, Schiedel D, Fischer D, Dekaban GA, Rieder MJ.

Can J Clin Pharmacol. 2002 Fall;9(3):137-46. Review.

PMID:
12422251
10.

Hepatotoxicity and antiretroviral therapy with protease inhibitors: A review.

Bruno R, Sacchi P, Maiocchi L, Patruno S, Filice G.

Dig Liver Dis. 2006 Jun;38(6):363-73. Epub 2006 May 2. Review.

PMID:
16631422
11.

[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].

Pozio E.

Parassitologia. 2004 Jun;46(1-2):89-93. Review. Italian.

PMID:
15305694
12.
13.

Tolerability and safety of HIV protease inhibitors in adults.

Sax PE, Kumar P.

J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1111-24. Review. Erratum in: J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1434.

PMID:
15319670
14.

Protease inhibitors and avascular necrosis: a systematic review and meta-analysis.

Permpalung N, Ungprasert P, Summachiwakij S, Leeaphorn N, Knight EL.

Int J Antimicrob Agents. 2014 Aug;44(2):93-5. doi: 10.1016/j.ijantimicag.2014.02.011. Epub 2014 Mar 28. Review.

PMID:
24726526
15.

[Osteonecrosis: a rare complication of HIV infection. Association with certain risk factors].

Meyer D, Behrens G, Stoll M, Schmidt RE.

MMW Fortschr Med. 2000 Mar 13;142 Suppl 1:64-7. Review. German.

PMID:
10863317
16.

Avascular necrosis of bone in patients with human immunodeficiency virus infection: report of 6 cases and review of the literature.

Brown P, Crane L.

Clin Infect Dis. 2001 Apr 15;32(8):1221-6. Epub 2001 Mar 26. Review.

PMID:
11283813
17.

[Clinical studies on the use of protease inhibitors in HIV infection. Answers and questions].

Fätkenheuer G, Salzberger B, Franzen C, Diehl V.

Internist (Berl). 1998 Sep;39(9):927-34. Review. German. No abstract available.

PMID:
9788114
18.

Osteonecrosis and highly active antiretroviral therapy during HIV infection: report of a series and literature review.

Calza L, Manfredi R, Mastroianni A, Chiodo F.

AIDS Patient Care STDS. 2001 Jul;15(7):385-9. Review.

PMID:
11483165

Supplemental Content

Support Center